• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉瘤的免疫治疗与放化疗联合应用。

Immunotherapy and Radiotherapy Combinations for Sarcoma.

机构信息

Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL.

Division of Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL..

出版信息

Semin Radiat Oncol. 2024 Apr;34(2):229-242. doi: 10.1016/j.semradonc.2023.12.005.

DOI:10.1016/j.semradonc.2023.12.005
PMID:38508787
Abstract

Sarcomas are a heterogeneous group of bone and soft tissue tumors. Survival outcomes for advanced (unresectable or metastatic) disease remain poor, so therapeutic improvements are needed. Radiotherapy plays an integral role in the neoadjuvant and adjuvant treatment of localized disease as well as in the treatment of metastatic disease. Combining radiotherapy with immunotherapy to potentiate immunotherapy has been used in a variety of cancers other than sarcoma, and there is opportunity to further investigate combining immunotherapy with radiotherapy to try to improve outcomes in sarcoma. In this review, we describe the diversity of the tumor immune microenvironments for sarcomas and describe the immunomodulatory effects of radiotherapy. We discuss studies on the timing of radiotherapy relative to immunotherapy and studies on the radiotherapy dose and fractionation regimen to be used in combination with immunotherapy. We describe the impact of radiotherapy on the tumor immune microenvironment. We review completed and ongoing clinical trials combining radiotherapy with immunotherapy for sarcoma and propose future directions for studies combining immunotherapy with radiotherapy in the treatment of sarcoma.

摘要

肉瘤是一组异质性的骨和软组织肿瘤。晚期(不可切除或转移性)疾病的生存结果仍然很差,因此需要治疗上的改进。放射治疗在局部疾病的新辅助和辅助治疗以及转移性疾病的治疗中发挥着重要作用。除肉瘤外,放射治疗与免疫治疗相结合以增强免疫治疗已在多种癌症中得到应用,有机会进一步研究将免疫治疗与放射治疗相结合,以试图改善肉瘤的治疗效果。在这篇综述中,我们描述了肉瘤的肿瘤免疫微环境的多样性,并描述了放射治疗的免疫调节作用。我们讨论了放射治疗与免疫治疗的时间关系的研究,以及与免疫治疗联合使用的放射治疗剂量和分割方案的研究。我们描述了放射治疗对肿瘤免疫微环境的影响。我们回顾了已完成和正在进行的联合放射治疗和免疫治疗肉瘤的临床试验,并为将免疫治疗与放射治疗相结合治疗肉瘤的研究提出了未来的方向。

相似文献

1
Immunotherapy and Radiotherapy Combinations for Sarcoma.肉瘤的免疫治疗与放化疗联合应用。
Semin Radiat Oncol. 2024 Apr;34(2):229-242. doi: 10.1016/j.semradonc.2023.12.005.
2
The value of adjuvant chemotherapy in the management of sarcomas in children.辅助化疗在儿童肉瘤治疗中的价值。
Cancer. 1985 May 1;55(9 Suppl):2184-97. doi: 10.1002/1097-0142(19850501)55:9+<2184::aid-cncr2820551422>3.0.co;2-n.
3
Radiation Therapy for Soft Tissue Sarcoma: Indications and Controversies for Neoadjuvant Therapy, Adjuvant Therapy, Intraoperative Radiation Therapy, and Brachytherapy.软组织肉瘤的放射治疗:新辅助治疗、辅助治疗、术中放射治疗和近距离放射治疗的适应证及争议
Surg Oncol Clin N Am. 2016 Oct;25(4):841-60. doi: 10.1016/j.soc.2016.05.012. Epub 2016 Aug 6.
4
Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).儿科非横纹肌肉瘤软组织肉瘤:欧洲儿科软组织肉瘤研究组(EpSSG)的前瞻性 NRSTS 2005 研究。
Lancet Child Adolesc Health. 2021 Aug;5(8):546-558. doi: 10.1016/S2352-4642(21)00159-0. Epub 2021 Jun 30.
5
Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma.软组织肉瘤免疫检查点阻断的原理和新兴策略。
Cancer. 2018 Oct 1;124(19):3819-3829. doi: 10.1002/cncr.31517. Epub 2018 May 3.
6
Adjuvant therapy for soft tissue sarcoma.软组织肉瘤的辅助治疗。
J Natl Compr Canc Netw. 2005 Mar;3(2):207-13. doi: 10.6004/jnccn.2005.0013.
7
Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.软组织肉瘤的辅助和新辅助化疗:JCOG 骨和软组织肿瘤研究组。
Jpn J Clin Oncol. 2021 Feb 8;51(2):180-184. doi: 10.1093/jjco/hyaa231.
8
[What is new in the local approach of limb sarcomas and desmoid tumours?].[肢体肉瘤和硬纤维瘤局部治疗方法的新进展有哪些?]
Cancer Radiother. 2010 Oct;14(6-7):455-9. doi: 10.1016/j.canrad.2010.06.016. Epub 2010 Aug 24.
9
Radiotherapy for pediatric non-rhabdomyosarcoma soft tissue sarcomas: a comprehensive review.小儿非横纹肌肉瘤软组织肉瘤的放射治疗:全面综述。
Turk J Pediatr. 2023;65(3):362-376. doi: 10.24953/turkjped.2022.1049.
10
Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.新辅助长春新碱、异环磷酰胺和阿霉素联合粒细胞集落刺激因子支持治疗晚期非横纹肌肉瘤软组织肉瘤儿童和青少年的II期试验:一项儿科肿瘤学组研究
J Clin Oncol. 2005 Jun 20;23(18):4031-8. doi: 10.1200/JCO.2005.03.209. Epub 2005 Mar 14.

引用本文的文献

1
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma.免疫疗法在未分化多形性肉瘤和黏液纤维肉瘤治疗中的应用
Curr Treat Options Oncol. 2025 Sep 1. doi: 10.1007/s11864-025-01349-x.
2
The human STING agonist E7766 induces immunogenic tumor clearance, independent of tumor-intrinsic STING expression in the murine model of sarcoma.人类STING激动剂E7766可诱导免疫原性肿瘤清除,在肉瘤小鼠模型中与肿瘤内在的STING表达无关。
Oncoimmunology. 2025 Dec;14(1):2534912. doi: 10.1080/2162402X.2025.2534912. Epub 2025 Jul 22.
3
Neoadjuvant Immunotherapy for Resectable Dedifferentiated Liposarcoma: A National Cohort Analysis.
可切除去分化脂肪肉瘤的新辅助免疫治疗:一项全国队列分析。
J Surg Oncol. 2025 Jun;131(8):1683-1691. doi: 10.1002/jso.28155. Epub 2025 May 13.